Other

FDA grapples with 'living' medical devices

Imagine a not-too-distant future when medical devices powered by artificial intelligence continuously adapt to new symptoms presented by patients and learn how to make accurate diagnoses much like a well-trained physician ...

Diabetes

Dapagliflozin improves glucose outcomes in type 1 diabetes

(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.

Diseases, Conditions, Syndromes

New gene variant is even more resistant to hospital antiseptic

A team of investigators has discovered a new, more powerful variant on an antimicrobial resistance gene common among Staphylococcus species. The gene protects the bacteria from an antiseptic compound widely used in healthcare. ...

Medications

FDA warns against use of preowned or unauthorized test strips

(HealthDay)—The U.S. Food and Drug Administration is warning patients not to use preowned test strips or test strips not authorized for sale in the United States because of possible infection or inaccurate results that ...

Radiology & Imaging

Performance improvement sustained after DBT adoption

(HealthDay)—Performance improvements after adoption of digital breast tomosynthesis (DBT) relative to digital mammography (DM) performance have been sustained, regardless of DBT volume, according to a study published online ...

Diseases, Conditions, Syndromes

Sepsis common in terminal hospitalizations, discharges

(HealthDay)—More than half of hospitalized patients who die or are terminally discharged have sepsis, according to a study published online Feb. 15 in JAMA Network Open.

page 26 from 40